Structures by: Wang D. C.
Total: 57
C17H19N3O3S2
C17H19N3O3S2
Journal of Natural Products (2020)
a=6.2397(5)Å b=10.6635(10)Å c=12.6809(11)Å
α=90° β=93.931(5)° γ=90°
C20H27N3O3S2
C20H27N3O3S2
Journal of Natural Products (2020)
a=9.8333(3)Å b=10.2552(3)Å c=20.8770(7)Å
α=90° β=90° γ=90°
C30H21Cl2NO3S
C30H21Cl2NO3S
Organic letters (2015) 17, 24 6078-6081
a=7.3264(4)Å b=7.7051(6)Å c=23.3320(14)Å
α=84.5940(10)° β=88.837(2)° γ=82.4040(10)°
C31H23Cl2NO4S
C31H23Cl2NO4S
Organic letters (2015) 17, 24 6078-6081
a=9.8014(13)Å b=12.1207(15)Å c=13.323(3)Å
α=99.552(15)° β=106.402(16)° γ=111.742(12)°
C22H26ClN5O9
C22H26ClN5O9
Organic Chemistry Frontiers (2019) 6, 6 863
a=14.6444(2)Å b=19.0270(3)Å c=9.29920(10)Å
α=90° β=98.1150(10)° γ=90°
C25H22ClN5O8
C25H22ClN5O8
Organic Chemistry Frontiers (2019) 6, 6 863
a=8.9522(4)Å b=12.3288(5)Å c=12.6211(5)Å
α=103.938(3)° β=101.104(4)° γ=102.417(4)°
C21H22ClN5O8
C21H22ClN5O8
Organic Chemistry Frontiers (2019) 6, 6 863
a=25.9456(5)Å b=8.8451(3)Å c=23.3704(7)Å
α=90° β=101.146(3)° γ=90°
C38H34NO4PS
C38H34NO4PS
Organic Chemistry Frontiers (2016) 3, 3 385
a=13.8300(11)Å b=21.2702(18)Å c=14.1309(13)Å
α=90.00° β=119.452(3)° γ=90.00°
Poly[[decaaquabis(μ~6~-1,8-disulfonato-9<i>H</i>-carbazole-3,6-dicarboxylato)di-μ~3~-hydroxy-pentazinc] decahydrate]
C28H32N2O32S4Zn5
IUCrData (2019) 4, 5 x190667
a=7.3573(3)Å b=11.2345(5)Å c=12.9215(5)Å
α=74.215(4)° β=78.085(4)° γ=85.178(4)°
C25H36O4
C25H36O4
Organic & Biomolecular Chemistry (2018)
a=13.2880(5)Å b=6.3903(2)Å c=14.4021(5)Å
α=90° β=111.827(4)° γ=90°
C37H50O6,C2H3N
C37H50O6,C2H3N
Organic & Biomolecular Chemistry (2018)
a=13.9171(3)Å b=18.5603(4)Å c=27.1890(5)Å
α=90° β=90° γ=90°
C25H30O4,CH4O
C25H30O4,CH4O
Organic & Biomolecular Chemistry (2018)
a=7.7671(1)Å b=16.3554(3)Å c=17.5789(3)Å
α=90° β=90° γ=90°
C20H19BrN2O6
C20H19BrN2O6
Chemical Communications (2019)
a=8.74390(10)Å b=12.3456(2)Å c=18.3547(3)Å
α=90° β=90° γ=90°
C15H18ClN5O3
C15H18ClN5O3
Chemical Communications (2019)
a=11.5414(2)Å b=7.33570(10)Å c=19.5853(3)Å
α=90° β=100.033(2)° γ=90°
Tert-Butyl (5aS,10bS,11aS)-6-acetyl-11a-hydroperoxy-3,3,10b-trimethyl-1,4-dioxo-1,3,4,5a,6,10b,11,11a-octahydro-2H-pyrazino[1',2':1,5]pyrrolo[2,3-b]indole-2-carboxylate (16)
C23H29N3O7,0.25(C3H6O),0.75(CH2Cl2)
Chemical Communications (2019)
a=8.3479(5)Å b=13.3110(7)Å c=13.7777(7)Å
α=108.424(2)° β=107.555(2)° γ=90.707(3)°
C20H17NO5
C20H17NO5
Chemical Communications (2019)
a=9.08830(10)Å b=9.08830(10)Å c=41.3484(8)Å
α=90° β=90° γ=90°
C18H15ClN2O5
C18H15ClN2O5
Chemical Communications (2018)
a=11.0671(2)Å b=11.0671(2)Å c=11.8214(2)Å
α=90° β=90° γ=120°
C31H23BrCl2INO5S2
C31H23BrCl2INO5S2
Chemical communications (Cambridge, England) (2016) 52, 9 1907-1910
a=11.1901(9)Å b=36.490(3)Å c=8.1940(7)Å
α=90.00° β=96.076(2)° γ=90.00°
Diethyl 2,3-O-benzylidene-D-tartarate
C15H18O6
Acta Crystallographica Section E (2007) 63, 3 o1093-o1094
a=7.5400(15)Å b=26.500(5)Å c=8.2100(16)Å
α=90.00° β=114.50(3)° γ=90.00°
Perhydrophthalimide
C8H11NO2
Acta Crystallographica Section E (2007) 63, 10 o3990-o3990
a=6.7574(12)Å b=7.8615(14)Å c=14.371(3)Å
α=90.00° β=90.00° γ=90.00°
3-(2-Bromo-4,5-dimethoxyphenyl)propiononitrile
C11H12BrNO2
Acta Crystallographica Section E (2008) 64, 6 o1064
a=17.552(3)Å b=17.552(3)Å c=7.4870(15)Å
α=90.00° β=90.00° γ=90.00°
Ethyl 4-amino-3-methylbenzoate
C10H13NO2
Acta Crystallographica Section E (2008) 64, 5 o785
a=8.0110(16)Å b=8.7030(17)Å c=15.835(3)Å
α=90.78(3)° β=95.13(3)° γ=114.34(3)°
Ethyl 1-cyclopropyl-6,7-difluoro-8-methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylate
C16H15F2NO4
Acta Crystallographica Section E (2008) 64, 11 o2214
a=16.395(3)Å b=17.732(4)Å c=12.199(2)Å
α=90.00° β=123.71(3)° γ=90.00°
(4<i>S</i>,5<i>S</i>)-2-(2-Fluorophenyl)-1,3-dioxolane-4,5-dicarboxamide
C11H11FN2O4
Acta Crystallographica Section E (2008) 64, 12 o2499
a=4.8760(5)Å b=9.1290(7)Å c=24.8160(9)Å
α=90.00° β=90.00° γ=90.00°
(<i>E</i>)-4-Bromo-<i>N</i>'-(2-nitrobenzylidene)benzohydrazide
C14H10BrN3O3
Acta Crystallographica Section E (2009) 65, 3 o508
a=4.8718(17)Å b=6.842(2)Å c=10.709(4)Å
α=98.014(5)° β=93.258(6)° γ=97.413(5)°
(4<i>S</i>,5<i>S</i>)-2-(4-Chlorophenyl)-1,3-dioxolane-4,5-dicarboxamide
C11H11ClN2O4
Acta Crystallographica Section E (2009) 65, 8 o1960
a=9.2780(19)Å b=4.7600(10)Å c=13.245(3)Å
α=90.00° β=93.15(3)° γ=90.00°
5-Methylisoxazole-4-carboxylic acid
C5H5NO3
Acta Crystallographica Section E (2009) 65, 12 o3140
a=7.2540(15)Å b=6.4700(13)Å c=12.273(3)Å
α=90.00° β=90.00° γ=90.00°
3-Chloroazepan-2-one
C6H10ClNO
Acta Crystallographica Section E (2010) 66, 2 o438
a=18.776(4)Å b=7.3440(15)Å c=11.109(2)Å
α=90.00° β=103.65(3)° γ=90.00°
(E)-4-Bromo-N'-(2-hydroxy-1-naphthylmethylene)benzohydrazide
C18H13BrN2O2
Acta Crystallographica Section E (2008) 64, 11 o2070
a=6.185(2)Å b=4.7638(19)Å c=25.689(10)Å
α=90.00° β=95.449(7)° γ=90.00°
(4<i>S</i>,5<i>S</i>)-2-(2-Thienyl)-1,3-dioxolane-4,5-dicarboxamide
C9H10N2O4S
Acta Crystallographica Section E (2009) 65, 4 o764
a=8.9250(18)Å b=4.7960(10)Å c=12.109(2)Å
α=90.00° β=90.60(3)° γ=90.00°
1<i>H</i>-Benzimidazole-2(3<i>H</i>)-thione
C7H6N2S
Acta Crystallographica Section E (2009) 65, 4 o756
a=4.9150(10)Å b=8.5590(17)Å c=8.2920(17)Å
α=90.00° β=91.76(3)° γ=90.00°
(4<i>S</i>,5<i>S</i>)-2-(2-Bromophenyl)-1,3-dioxolane-4,5-dicarboxamide
C11H11BrN2O4
Acta Crystallographica Section E (2009) 65, 4 o841
a=9.4150(19)Å b=14.458(3)Å c=9.6170(19)Å
α=90.00° β=111.14(3)° γ=90.00°
(4<i>S</i>,5<i>S</i>)-2-(3-Methoxyphenyl)-1,3-dioxolane-4,5-dicarboxamide
C12H14N2O5
Acta Crystallographica Section E (2009) 65, 9 o2230
a=9.2340(18)Å b=9.852(2)Å c=14.266(3)Å
α=90.00° β=90.00° γ=90.00°
1-Benzoyl-3-chloroazepan-2-one
C13H14ClNO2
Acta Crystallographica Section E (2009) 65, 10 o2383
a=19.564(4)Å b=7.6500(15)Å c=8.4050(17)Å
α=90.00° β=90.00° γ=90.00°
(<i>E</i>)-<i>N</i>'-(2,5-Dimethoxybenzylidene)-2,4-dihydroxybenzohydrazide
C16H16N2O5
Acta Crystallographica Section E (2010) 66, 4 o996
a=7.8600(16)Å b=15.358(3)Å c=12.425(3)Å
α=90.00° β=99.80(3)° γ=90.00°
2-[(4,6-Dimethoxypyrimidin-2-yl)oxy]benzaldehyde
C13H12N2O4
Acta Crystallographica Section E (2012) 68, 2 o423
a=3.9920(8)Å b=7.3670(15)Å c=20.885(4)Å
α=90.00° β=94.87(3)° γ=90.00°
6-Amino-2-methyl-8-phenyl-1,2,3,4-tetrahydroisoquinoline-5,7-dicarbonitrile
C18H16N4
Acta Crystallographica Section E (2013) 69, 6 o929
a=17.5630(5)Å b=6.25208(19)Å c=13.7963(4)Å
α=90.00° β=93.209(3)° γ=90.00°
2-(Hydroxymethyl)pyridin-3-ol
C6H7NO2
Acta Crystallographica Section E (2012) 68, 3 o722
a=7.0430(14)Å b=7.1280(14)Å c=12.264(3)Å
α=90.00° β=100.30(3)° γ=90.00°
<i>N</i>-Cyclohexyl-<i>N</i>-{[3-(4,6-dimethoxypyrimidin-2-yloxy)pyridin- 2-yl]methyl}4,6-dimethoxypyrimidin-2-amine
C24H30N6O5
Acta Crystallographica Section E (2012) 68, 4 o1272
a=7.0260(14)Å b=10.624(2)Å c=17.084(3)Å
α=72.95(3)° β=84.18(3)° γ=79.56(3)°
2-(1-Methyl-2-oxoindolin-3-ylidene)malononitrile
C12H7N3O
Acta Crystallographica Section E (2013) 69, 7 o1095
a=6.9720(14)Å b=9.929(2)Å c=15.084(3)Å
α=90.00° β=100.25(3)° γ=90.00°
<i>N</i>-(2,6-Dichlorophenyl)-5-methyl-1,2-oxazole-4-carboxamide monohydrate
C11H8Cl2N2O2,H2O1
Acta Crystallographica Section E (2011) 67, 12 o3207
a=12.047(2)Å b=8.2290(16)Å c=13.086(3)Å
α=90.00° β=90.00° γ=90.00°
2-Chloro-<i>N</i>-(4-chloro-3-iodophenyl)-4-(methylsulfonyl)benzamide
C14H10Cl2INO3S
Acta Crystallographica Section E (2012) 68, 1 o189
a=8.8694(6)Å b=10.3837(8)Å c=10.4288(5)Å
α=103.862(5)° β=96.452(5)° γ=114.949(7)°
1-Benzyl-6-chloroindoline-2,3-dione
C15H10ClNO2
Acta Crystallographica Section E (2011) 67, 12 o3427
a=7.1870(14)Å b=7.5800(15)Å c=12.012(2)Å
α=80.24(3)° β=84.90(3)° γ=79.74(3)°
<i>N</i>-(4-Chloro-2-nitrophenyl)-5-methylisoxazole-4-carboxamide
C11H8ClN3O4
Acta Crystallographica Section E (2011) 67, 12 o3332
a=5.3870(11)Å b=23.537(5)Å c=9.4600(19)Å
α=90.00° β=99.86(3)° γ=90.00°
1-Benzyl-4-chloroindoline-2,3-dione
C15H10ClNO2
Acta Crystallographica Section E (2012) 68, 1 o37
a=22.864(5)Å b=16.600(3)Å c=13.335(3)Å
α=90.00° β=90.00° γ=90.00°
6-Chloro-1-methylindoline-2,3-dione
C9H6ClNO2
Acta Crystallographica Section E (2012) 68, 1 o14
a=13.077(3)Å b=7.9390(16)Å c=16.673(3)Å
α=90.00° β=101.95(3)° γ=90.00°
4-Chloro-1-methylindoline-2,3-dione
C9H6ClNO2
Acta Crystallographica Section E (2012) 68, 1 o219
a=7.4890(15)Å b=14.825(3)Å c=7.3140(15)Å
α=90.00° β=90.27(3)° γ=90.00°
[2-(1<i>H</i>-Indol-4-yl)ethyl]dipropylamine
C16H24N2
Acta Crystallographica Section E (2012) 68, 5 o1502
a=12.1100(9)Å b=15.5996(12)Å c=16.0253(12)Å
α=90.00° β=90.00° γ=90.00°
5-Methyl-<i>N</i>-[2-(trifluoromethyl)phenyl]isoxazole-4-carboxamide
C12H9F3N2O2
Acta Crystallographica Section E (2012) 68, 5 o1450
a=15.839(3)Å b=8.3260(17)Å c=9.4250(19)Å
α=90.00° β=101.29(3)° γ=90.00°
<i>rac</i>-Methyl 2-(2-formyl-4-nitrophenoxy)hexanoate
C14H17NO6
Acta Crystallographica Section E (2012) 68, 5 o1395
a=14.918(3)Å b=4.9220(10)Å c=20.928(4)Å
α=90.00° β=103.26(3)° γ=90.00°
<i>N</i>'-(2-Chlorobenzylidene)-4-methylbenzohydrazide
C15H13ClN2O
Acta Crystallographica Section E (2012) 68, 6 o1960
a=11.0697(14)Å b=13.4436(16)Å c=9.1643(11)Å
α=90.00° β=96.576(2)° γ=90.00°
<i>N</i>-(2,4-Difluorophenyl)-5-methyl-1,2-oxazole-4-carboxamide hemihydrate
C11H8F2N2O2,0.5(H2O)
Acta Crystallographica Section E (2012) 68, 8 o2325
a=15.182(3)Å b=13.803(3)Å c=12.159(2)Å
α=90.00° β=120.06(3)° γ=90.00°
5-Methyl-<i>N</i>-(1,3-thiazol-2-yl)isoxazole-4-carboxamide
C8H7N3O2S
Acta Crystallographica Section E (2013) 69, 6 o853
a=8.8460(18)Å b=10.742(2)Å c=10.024(2)Å
α=90.00° β=107.27(3)° γ=90.00°
C39H34FNO8S3
C39H34FNO8S3
The Journal of organic chemistry (2018) 83, 17 9641-9653
a=13.6597(13)Å b=23.060(2)Å c=12.2080(12)Å
α=90.00° β=111.881(3)° γ=90.00°
C26H21ClF2O3S
C26H21ClF2O3S
The Journal of organic chemistry (2018) 83, 17 9641-9653
a=7.9914(7)Å b=15.5578(13)Å c=18.6615(15)Å
α=90.00° β=94.9260(10)° γ=90.00°
C30H28ClNO3S
C30H28ClNO3S
Journal of the American Chemical Society (2015) 137, 28 8928-8931
a=12.2443(7)Å b=11.5289(6)Å c=18.6517(10)Å
α=90.00° β=95.401(3)° γ=90.00°
C34H33NO5S
C34H33NO5S
Journal of the American Chemical Society (2015) 137, 28 8928-8931
a=9.1694(2)Å b=10.3934(2)Å c=15.8101(3)Å
α=93.0780(10)° β=96.2050(10)° γ=94.9870(10)°